Status: Not yet recruiting
Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy
The goal of this prospective, exploratory, non-intervention, multi-center, real-world study is to investigate the predictive value of HBV pgRNA in the occurrence of long-term outcomes under antiviral therapy in patients with chronic hepatitis B. Participants will take the necessary clinical examination and blood draw during the patient's treatment and follow-up, and all the treatment is determined by clinicians.
Participants needed: 5,000
Trial details
Age: 18-80Biological sex: AllType: ObservationalSponsor: Wen-hong ZhangUpdated: Jul 28, 2023Locations: 10
Eligibility criteria
CHB defined as positive hepatitis B surface antigen at least 6 months, or HBV-re... [+3]
Patients with malignancies other than hepatocellular carcinoma.